Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription

Articles published in BMJ

Retrieve available abstracts of 30 articles:
HTML format
Text format

Single Articles

    March 2018
  1. MAYOR S
    Alzheimer's disease research: five minutes with John Hardy.
    BMJ. 2018;360:k1163.
    PubMed     Text format    

    January 2018
    Pfizer abandons research into Alzheimer's and Parkinson's diseases.
    BMJ. 2018;360:k122.
    PubMed     Text format    

    December 2017
  3. LARSSON SC, Traylor M, Malik R, Dichgans M, et al
    Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis.
    BMJ. 2017;359:j5375.
    PubMed     Text format     Abstract available

  4. SOMMERLAD A, Livingston G
    Preventing Alzheimer's dementia.
    BMJ. 2017;359:j5667.
    PubMed     Text format    

    June 2017

  5. Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study.
    BMJ. 2017;357:j3170.
    PubMed     Text format    

    Proton pump inhibitor use does not raise dementia and Alzheimer's risk, study suggests.
    BMJ. 2017;357:j3063.
    PubMed     Text format    

    April 2017
  7. BENN M, Nordestgaard BG, Frikke-Schmidt R, Tybjaerg-Hansen A, et al
    Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study.
    BMJ. 2017;357:j1648.
    PubMed     Text format     Abstract available

  8. WISE J
    Vascular risk factors show link to development of Alzheimer's.
    BMJ. 2017;357:j1847.
    PubMed     Text format    

    February 2017
    Merck ends trial of potential Alzheimer's drug verubecestat.
    BMJ. 2017;356:j845.
    PubMed     Text format    

    December 2016
  10. LE COUTEUR DG, Hunter S, Brayne C
    Solanezumab and the amyloid hypothesis for Alzheimer's disease.
    BMJ. 2016;355:i6771.
    PubMed     Text format    

  11. MAYOR S
    Statins are linked to reduced Alzheimer's risk, study finds.
    BMJ. 2016;355:i6675.
    PubMed     Text format    

    November 2016
  12. HAWKES N
    Sixty seconds on . . . solanezumab.
    BMJ. 2016;355:i6389.
    PubMed     Text format    

  13. HAWKES N
    Promise of new Alzheimer's drug is dashed after lack of evidence.
    BMJ. 2016;355:i6362.
    PubMed     Text format    

    January 2016
  14. HAWKES N
    Amyloid plaques are still main target for Alzheimer's drugs.
    BMJ. 2016;352:i214.
    PubMed     Text format    

  15. WISE J
    Higher levels of mercury in brain are not linked to increased risk of Alzheimer's, study finds.
    BMJ. 2016;352:i611.
    PubMed     Text format    

  16. GRAY SL, Dublin S, Yu O, Walker R, et al
    Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study.
    BMJ. 2016;352:i90.
    PubMed     Text format     Abstract available

  17. WISE J
    No "breakthrough" in Alzheimer's disease.
    BMJ. 2016;354:i4474.
    PubMed     Text format    

  18. WISE J
    Dementia and flu are blamed for increase in deaths in 2015 in England and Wales.
    BMJ. 2016;353:i2022.
    PubMed     Text format    

    Approved drugs are to be studied for use in Alzheimer's disease.
    BMJ. 2016;354:i5063.
    PubMed     Text format    

    January 2015
  20. HAWKES N
    Hopes rise for new Alzheimer's drug after secondary analysis.
    BMJ. 2015;351:h4048.
    PubMed     Text format    

    Margaret McCartney: The "breakthrough" drug that's not been shown to help in Alzheimer's disease.
    BMJ. 2015;351:h4064.
    PubMed     Text format    

    Need for a trial of solanezumab in mild Alzheimer's disease.
    BMJ. 2015;351:h4441.
    PubMed     Text format    

  23. MAYOR S
    Peptides that form amyloid plaques in Alzheimer's may be transmissible, study finds.
    BMJ. 2015;351:h4831.
    PubMed     Text format    

  24. WISE J
    Combination drug shows promise for treating agitation in patients with Alzheimer's disease.
    BMJ. 2015;351:h5015.
    PubMed     Text format    

  25. COHEN JP, Dong J, Lu CY, Chakravarthy R, et al
    Restricting access to florbetapir: Medicare coverage criteria for diagnostics and drugs are inconsistent.
    BMJ. 2015;351:h3333.
    PubMed     Text format    

    Continuing donepezil when Alzheimer symptoms worsen might delay nursing home admission, study indicates.
    BMJ. 2015;351:h5739.
    PubMed     Text format    

    Author's reply to Karran.
    BMJ. 2015;351:h4532.
    PubMed     Text format    

  28. KARRAN E
    Recent trial shows that solanezumab has disease modifying effects.
    BMJ. 2015;351:h4528.
    PubMed     Text format    

  29. MAYOR S
    Slow walking speed may be early sign of Alzheimer's in older people, study finds.
    BMJ. 2015;351:h6506.
    PubMed     Text format    

  30. ZUCKERMAN DM, Jury NJ, Silcox CE
    21st Century Cures Act and similar policy efforts: at what cost?
    BMJ. 2015;351:h6122.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.